Cell Death Mechanisms of the Promising Anticancer Compound Gallotannin by Houssein, Marwa & Gali-Muhtasib, Hala
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter
Cell Death Mechanisms of the
Promising Anticancer Compound
Gallotannin
Marwa Houssein and Hala Gali-Muhtasib
Abstract
The polyphenolic hydrolyzable tannin, gallotannin (GT), also known as tannic
acid, possesses interesting anticarcinogenic properties. An evidence from experi-
mental studies suggests that GT is effective against multiple cancer types.
Gallotannin has been shown to induce programmed cell death in a wide variety of
cancers including colon, breast, prostate, and liver, among others. Apoptosis, cellu-
lar senescence, autophagy, and necrosis are the main mechanisms by which GT can
suppress cancer progression. In addition, GT is a potent inhibitor of many prolifer-
ation pathways. Herein, this chapter provides a summary of our current knowledge
about GT’s programmed cell death mechanisms against cancer.
Keywords: programmed cell death, apoptosis, autophagy, necroptosis, cellular
senescence, polyphenols, gallotannin, cancer
1. Introduction
Over the past decade, cancer was considered as the major public health concern
and one of the leading causes of death worldwide with 9.6 million cancer deaths
reported in 2018. The main recurrent cancers are lung, colorectal, stomach, liver,
prostate, and breast. Various external (tobacco, radiation, infections, nutrition) and
internal (mutations, hormones, and immune conditions) factors contribute to can-
cer incidence. Described as a group of diseases characterized by uncontrolled pro-
liferation and growth of abnormal cells, cancer is mainly characterized by its
resistance to cell death and sustained activation of proliferation pathways.
Throughout life, there is a balance between cell death and cell proliferation [1]. Any
imbalance favoring one process over the other would contribute to the development
of significant disorders such as autoimmune diseases, cancer, AIDS, neurodegener-
ative disorders, myocardial infarctions, atherosclerosis, and insulin-dependent dia-
betes. Furthermore, cell death can be divided into two forms: regulated and
accidental. Unlike regulated cell death which relies on the activation of signal
transduction cascades and can be modulated pharmacologically or genetically, acci-
dental cell death occurs immediately in response to physical (high pressure, osmotic
forces, temperatures, etc.), chemical (extreme pH variations, etc.), or mechanical
(shear forces, etc.) cues that occur in an uncontrollable form [2]. Besides apoptosis,
there are many forms of programmed cell death, namely, necroptosis, cellular
senescence, autophagy, slow cell death, and paraptosis [3].
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One third of all cancers can be prevented by a healthy lifestyle which includes an
appropriate and balanced nutrition [4]. There is a growing interest in using dietary
compounds as preventive and therapeutic agents in cancer due to their relative
safety, their immediate action on target tissues, and their specific action against
cancer cells [5]. The protective effects of dietary compounds are a consequence of
different modes of action such as their ability to neutralize carcinogens, hamper the
transcription of oncogenes, activate detoxifying enzymes, and trigger cell death in
mutated and cancerous cells.
Polyphenols are a group of phytochemicals that when consumed decrease the
risk of chronic diseases especially cancer. They are effective in treating solid tumors
by inducing a cohort of effects such as cell cycle arrest and cell death [6]. The
polyphenolic hydrolyzable tannin, gallotannin, and penta-1, 2, 3, 4, 6-O-galloyl--
beta-D-glucose (PGG), a precursor of GT, have been shown to exert various bio-
logical effects ranging from anti-inflammatory to anticancer effects in various
tumor cells [7]. Thus, current research aims at developing therapeutic approaches
that would benefit from the interconnected matrix of signaling pathways and the
ability of natural compounds to induce programmed cell death processes that could
prevent and restrain tumor development.
2. Programmed cell death mechanisms
2.1 Apoptosis
Each day, our body eliminates, via apoptosis, billions of unwanted cells. In
addition to being essential for development and homeostasis, apoptosis is the major
mechanism of programmed cell death. During apoptosis, apoptotic cells undergo
characteristic changes in cell morphology, including shrinkage of nuclei, nuclear
chromatin condensation, cytoplasmic shrinkage, dilated endoplasmic reticulum,
membrane blebbing, and the exposure of specific phagocytic signaling molecules on
the cell surface [8]. The contents of the cell are englobed in apoptotic bodies which
are then recognized by the phagocytic cells and digested in lysosomes. In most cells,
apoptosis leads to the activation of caspases which mediates the auto destruction of
the cell. Caspases, a family of cysteine proteases, exist as inactive precursors (pro-
caspases) and are activated upon cleavage. The C-terminal side of a four amino acid
motif, X-X-X-Asp (where X can be any amino acid) is the preferred cleavage site
for the known caspases. Activated caspases in turn cleave various intracellular and
cytoplasmic membrane substrates, leading to cellular disintegration [9].
2.1.1 Apoptotic pathways
In the mammalian system, two major pathways lead to apoptosis: the intrinsic
pathway which involves the mitochondria and the extrinsic pathway which is
initiated by death receptors [10]. The intrinsic pathway of apoptosis is mediated by
the Bcl-2 family protein (also known as mitochondrial or stress pathway). Bcl-2
family, composed of both anti-apoptotic and pro-apoptotic proteins, is generally
divided into three subgroups based on their roles in apoptosis and the BH regions
they share: one anti-apoptotic group and two pro-apoptotic groups. The anti-
apoptotic group includes Bcl-2, Bcl-xL, Bcl-w, Bcl-B, A1, and Mcl-1, which share
three or four BH regions. The pro-apoptotic Bcl-2 family members include Bax,
Bak, Bcl-xs, Bok, and Bcl-GL, which have two or three BH domains. Another pro-
apoptotic group contains the BH3-only proteins, including Bad, Bid, Bim, Bik,
Noxa, Puma, Bcl-Gs, Blk, Bmf, and Hrk, which share only the BH3 domain. A key
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event of the intrinsic pathway is the mitochondrial outer membrane permeabilization
(MOMP) process, which is considered the point-of-no return in apoptosis induction.
Normally, the anti-apoptotic members of the Bcl2 family prevent MOMP [11]. In
response to stress stimuli such as oncogenes, direct DNA damage, oxidative stress,
and starvation, two pro-apoptotic proteins, Bax and Bak, become activated by BH3-
only proteins that serve as sensors for apoptotic stimuli. Once activated, Bax and Bak
permeabilize the outer membrane of mitochondria, causing the release of pro-
apoptotic factors such as cytochrome c. In the cytosol, cytochrome c binds to mono-
meric apoptotic protease activating factor-1 (APAF-1) at its WD40 domain and
induces a conformational change in APAF-1 promoting APAF-1 oligomerization and
initiating the formation of the apoptosome. APAF-1 then binds to pro-caspase 9
resulting in its auto-cleavage and release of active caspase 9. Active caspase 9 then
cleaves the effector caspases, such as caspase 3 and caspase 7, resulting in their
activation and promoting the cell death process. The extrinsic pathway or death
receptor pathway involves the binding of ligands to cell surface “death receptors”
which in turn initiate the caspase cascade. Death receptors, located on the cell mem-
brane, are members of the TNFR family and are characterized by the presence of a
death domain (DD) that plays a crucial role in apoptotic signal transduction [12]. The
best characterized ligands and their corresponding death receptors include TNF-
α/TNF-R1, FasL/FasR, APO3L/DR3, TRAIL/TRAIL-R1, TRAIL/TRAIL-R2, and
TRADD/DR6. The binding of death ligands results in the oligomerization and the
activation of the death receptors. Oligomerization of the receptors is followed by
binding of specific adapter proteins (FADD, TRADD) to their receptor, which in turn
leads to the activation of the caspase signaling pathway. FADD binds to pro-caspase 8
through its dead effector domain (DED) allowing the formation of DISC, the death-
inducing signaling complex, and the autocatalytic activation of pro-caspase-8. Active
caspase-8 executes the apoptotic process through direct cleavage and activation of
effector caspases (caspases 3, 6, and 7) [13].
2.1.2 Apoptosis and cancer
The evasion of apoptosis is one of the prominent hallmarks of cancer cells. This
is the result of mutations in apoptosis-related genes. The Bcl-2 family members, Fas,
p53, and c-Myc are the common mutated genes in cancer. Overall, malignant cells,
in different kinds of cancers, have an anti-apoptotic phenotype with low level of
pro-apoptotic proteins such as Bax and high level of anti-apoptotic proteins such as
Bcl-2 and Bcl-xL. The tumor suppressor p53 is mutated in most cancers including
colorectal carcinoma, brain and lung cancer, mammary carcinoma, and skin and
bladder carcinomas. The overexpression of inhibitor apoptosis proteins (IAP) and
downregulation of surface death receptors (CD95, DR4, and DR5) were also
detected in cancer cells [14].
2.2 Cellular senescence
Senescence is a normal process caused by telomere shortening after successive cell
divisions of normal somatic cells. This process irreversibly halts the cell from prolif-
eration. In addition to being a normal process, senescence can be activated in
response to oncogenic activation, oxidative stress, and DNA damage. Morphologi-
cally, senescent cells can be distinguished by their enlarged, flattened, and granular
morphology; nuclear enlargement; and altered chromatin structure [15]. Biochemi-
cally, cellular senescence is characterized by an enhanced β-galactosidase activity,
inhibition of cyclin-dependent kinases (CDKs), the absence of proliferation markers,
and the presence of senescence-associated heterochromatin foci (SAHF) [2].
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2.2.1 Pathways of cellular senescence
The molecular pathways of senescent cells are not unique but differ between
cells from different species and among different cell types from the same species.
The heterogeneous pathways of senescence, however, meet at p53 and p-Rb [16]. In
the p53-p21 pathway, p53 is the important player of the senescence response. The
expression of the phosphorylated form of p53 increases in senescent cells leading to
an increase in its transcriptional activity. P53 is activated in response to shortened
telomeres that activate a DNA damage cascade through ATM/ATR and Chk1/Chk2
resulting in G1 phase arrest. P53 is also activated in response to DNA damage,
oxidative stress, and activation of Ras oncogene leading to telomere-independent
premature senescence. One of the most important targets of p53 is p21 which can
also be expressed in a p53-independent manner [17]. Some cell types have been
found to undergo senescence upon overexpressing p21 and escape senescence upon
its deletion. Mouse embryonic fibroblasts lacking p21 undergo senescence
suggesting that senescence can occur in a p21-independent manner in these rodent
cells [18]. In the p16-pRb pathway, p53 and p-Rb are thought to act simultaneously
to achieve senescence because their concomitant inactivation is needed to terminate
the senescence response in human cells. The phosphorylation state of Rb controls
the progression through the cell cycle. When phosphorylated by cyclin-dependent
kinases, p-Rb liberates E2F transcription factor that transcribes target genes
responsible for DNA replication and progression through the cell cycle. Inhibition
of CDKs by cyclin-dependent kinase inhibitors prevents the phosphorylation of Rb.
When hypophosphorylated, Rb binds E2F, thus preventing the transcription of E2F
target genes [19]. CDKIs belong to two families: the CIP/KIP family including p21,
p27, and, p57 and the INK4 family including p15, p16, p18, and p19. P16 expression
is found to be high in senescent cells driven to cell cycle arrest by stressful stimuli
such as DNA damage, oxidative stress, and oncogenic Ras activation. Both p53-p21
and p16-pRb senescent pathways converge on inhibiting the phosphorylation of Rb
[20]. In some cases, senescence is hindered by the inhibition of either p53 or p-Rb
which suggests a sole p53 and p-Rb signaling pathway. In other cases, inhibiting
senescence requires the inactivation of both p53 and p-Rb supporting the existence
of two simultaneous pathways. This variation in the molecular mechanisms of the
senescence signaling pathway depends on several factors including p16 expression,
the type of cell line, culture conditions, and the amount of stress [21].
2.2.2 Cellular senescence and cancer
Senescence represents a fail-safe mechanism that guards against oncogenic
transformation [22]. Cancer arises after a normal cell accumulates several mutations
that are inherited with each replicative cycle. Senescence helps limit the accumula-
tion of mutations by restricting the replicative ability of normal cells, thereby
preventing cancer development [23]. Furthermore, it has been shown that initial
oncogenic events will lead to senescence, and at that point the senescence-
associated secretory phenotype will induce immune clearance limiting early tumor
growth [24]. But many cancerous cells acquire indefinite proliferation by escaping
senescence through different mechanisms that inhibit telomere shortening such as
triggering telomerases or increasing telomere length by homologous recombination
or inhibiting tumor suppressors. In fact, various tumor suppressors and oncogenes
have been shown to regulate senescence in normal cells, and senescence bypass
appears to be an important step in the development of cancer [25]. For instance,
inhibiting BRAF-induced senescence by the loss of the tumor suppressor PTEN will
lead to melanoma progression [18]. Thus, evading senescence is an important step
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toward full malignancy and metastasis. Tumor cells may escape senescence indi-
rectly by acquiring mutations that affect senescence-related proteins such as the
tumor suppressor proteins p53 and p-Rb which are frequently mutated in cancer
[26]. Furthermore, many studies detected senescent cells in premalignant mice and
human tumors and not in the malignant tumors. This senescence response was
thought to have an antitumorigenic role in cancer-predisposed tissues [27].
Although most cancer cells bypass oncogene-induced senescence, various stud-
ies described the anticancer ability of chemotherapeutic drugs to induce senescence
in those cancer cells, an event which was termed as therapy-induced senescence.
2.3 Autophagy
In response to starvation, hypoxic conditions and high temperatures, and DNA
and organelle damage, the autophagy cell death process is activated. Double-
membrane cytoplasmic vesicles called autophagosomes engulf cytoplasmic organ-
elles and fuse to lysosomes to form autolysosomes when the cellular components are
digested [28].
2.3.1 Pathways of autophagy
Autophagy is driven by Atgs proteins and is regulated by PI3 kinase types I and
III. PI3K type 1 inhibits autophagy through PDK1 and AKT which regulate mTOR.
Atg6 (Beclin1) is part of PI3K type 3 complex which promotes the nucleation of
autophagic vesicles. In resting conditions, mTOR phosphorylates and inactivates
ULK1 (Atg1). Metabolic stress activates AMPK which inhibits mTOR activity and
activates ULK1 leading for the activation of the autophagy function of PI3K type 3
through Beclin1 phosphorylation [29]. The proteins Atg1 and Atg13 allow the
membrane isolation. Elongation is then mediated by Atg10, Atg5, and ATG12. The
recruitment of the cytoplasmic protein LC3 by Atg7, Atg4, and Atg3 to the nascent
autophagosome is necessary for the expansion and fusion events. The formation of
autolysosomes is not only sufficient for autophagic cell death; additional death
signals are still needed. Enhanced expression of c-Jun N-terminal kinase (JNK)
generates such signals and rapidly induces autophagy cell death [30].
2.3.2 Autophagy and cancer
Decreased rate of autophagic activity is related to tumorigenesis, and autophagic
cell death does not occur in most cancer cells. Beclin1 is downregulated in many
cancer types including prostate, breast, and ovarian cancer [31]. Mutations of Atg5
and LC3 (microtubule-associated protein 1 light chain 3B) promote myeloma and
glioblastoma, respectively [32]. JNK activation is significantly decreased in cancer
cells [33].
2.4 Necrosis
Although most scientists considered necrosis as accidental cell death and an
uncontrolled process, several studies showed that some forms of necrosis are
programmed [34]. Necroptosis is controlled by receptor interacting protein (RIP)
kinases, NADPH oxidases, poly(ADP-ribose) polymerase-1 (PARP1), and calpains
[35]. During necroptosis, the disruption of the cellular membrane integrity leads to
the release of the intracellular materials in the extracellular environment which
induce a local inflammatory response. These perturbations are detected by specific
death receptors such as FAS and TNFR1 or pathogen recognition receptors (PRRs)
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such as TLR3 and TLR4 [2]. The activation of receptors allows the activation of
RIPK1 which in turn activates RIPK3. The signaling complex formed by RIPK1 and
RIPK3 is known as necrosome and leads to the phosphorylation of mixed lineage
kinase domain-like pseudokinase (MLKL). The activation of MLKL results in the
formation of MLKL oligomers that upon translocation to the plasma membrane
trigger its permeabilization [30].
2.4.1 Necroptosis and cancer
Cancer cells evade necroptosis by downregulation or functional mutations of
RIP1, RIP3, andMLKL genes [36]. Colon cancer cells showed decreased levels of RIP1
and RIP3 expression [37]. A hypermethylation in the promoter region of RIP3 was
detected in lung cancer cells resulting in the loss of RIP3 expression [38]. Mutations in
RIP1, RIP3, and MLKL were observed in human cancer tissues which modulate the
RIP kinase interaction with other proteins or decrease their activity [39].
3. Polyphenols
Higher plants are found to have thousands of molecules with polyphenol struc-
tures, and edible plants are also found to contain several hundreds of these poly-
phenolic molecules. Plants generate these molecules as secondary metabolites that
have crucial roles in plant development, reproduction, and pigmentation. They also
have other roles like providing protection against diseases, parasites, ultraviolet
radiation, and predators [40]. Collectively, these chemicals are known as phyto-
chemicals which are categorized into five groups: carotenoids, phenolics, alkaloids,
nitrogen-containing compounds, and organosulfur compounds. Tannin, a subgroup
of phenolics and to which GT belongs, is further categorized into two biologically
and chemically distinct subtypes, the condensed and hydrolyzable tannins [41].
Condensed tannins, depending on their size, could be either soluble or insoluble,
whereby the oligomers are soluble, and the polymers are not. On the other hand, the
hydrolyzable tannins, also referred to as galloyl and hexahydroxydiphenol esters,
are composed of a β-D-glucose unit, linked to at least five galloyl groups through
ester bonds. GT, or tannic acid, belongs to this last group that is also characterized
by the presence of digalloyl residues consisting of meta-depside bonds between two
galloyl groups [42].
3.1 Polyphenols and cancer
Plant polyphenols were found to suppress tumor invasion and metastasis, such is
the case of green tea polyphenols, hydrolyzable tannins, grape seed, curcumin, and
resveratrol [43]. This inhibition potential is due to the downregulation of the matrix
metalloproteases (MMPs) by the natural phenolics [44]. Also, epigallocatechin
gallate (EGCG), the most abundant polyphenol found in tea, has been reported to
decrease the vascular endothelial growth factor (VEGF), thus inhibiting tumor
angiogenesis [45]. Indeed, there has been increased evidence over the years of the
effect of polyphenols on the fate of cancer cells leading to growth, differentiation,
and apoptosis. Phytochemicals contribute to cancer prevention by interfering in the
different stages of cancer development from tumor initiation and throughout all the
hallmarks of cancer [4]. Thus, one of the most studied and acclaimed biological
effects of polyphenols relates to its antioxidant properties; indeed polyphenols are
able to scavenge reactive oxygen species (ROS) including radical and nonradical
oxygen species such as O2
, HO, NO, H2O2, O2, and HOCl, as well as oxidatively
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generated free radicals ROC and ROOC such as those derived from biomolecules
such as low-density lipoproteins (LDLs), proteins, and oligonucleic acids (DNA and
RNA) [46]. Different human intervention studies on the health potential of poly-
phenols were conducted in healthy volunteers or on high-risk developing cancer
individuals. A one-dose diet rich in polyphenols, such as fruit juices, chocolate,
strawberries, and grape seed concentrate, was able to reduce the antioxidant status
and protect from oxidative stress [39]. In another study, hemodialysis patients
consumed 200 mL/day of red fruit juice, and the results showed a significant
decrease in DNA oxidation damage and NF-κB binding activity. In summary poly-
phenols exert their preventive effects on cancer cells via different mechanisms,
mainly via their antioxidant effects, antiproliferation and antisurvival effects,
induction of cell cycle arrest, induction of apoptosis, anti-inflammatory effects, and
inhibition of metastasis and angiogenesis [47].
4. Gallotannin
Gallotannin or tannic acid is a hydrolyzable tannin that is characterized by the
formation of meta-depside bonds between two galloyl groups resulting in digalloyl
residues [42].
4.1 Bioavailability, biodegradation, and absorption
Gallotannin is mainly present in mangoes, pomegranate, acorns, walnuts, and
beverages such as wine [48]. The metabolism of tannic acid was studied in a rat
model system [49]. Based on this study, the authors proposed that administered
tannic acid was not hydrolyzed by the acidity of the stomach but rather by tannase
enzymes produced by intestinal bacteria. Upon hydrolysis, tannic acid released
glucose and small phenolic acids which include gallic acid (GA), 4-O-methylgallic
acid (4-OMGA), resorcinol (RE), pyrogallol (PY), and ellagic acid (EA) [50]. It has
been postulated that GT hydrolysis could be measured by the release of gallic acid.
Gallic acid is further metabolized by the colon microflora into pyrogallol which is
ready to be absorbed by the intestinal cells [51].
4.2 Biosafety and toxicity
Dietary polyphenols are considered as safe and well-tolerated compounds. Only
few studies have reported toxicity and adverse effects induced by plant polyphenols
[52]. Tested on human epithelial and fibroblast cells, PGG did not show any toxicity
at concentrations below 50 μM [53]. Galla Rhois is the excrescence formed by
parasitic aphids, primarily Schlechtendalia chinensis Bell, on the leaf of sumac. The
gallotannin-enriched extract isolated from Galla Rhois (GEGR) was administered
orally to ICR mice using three different concentrations (250, 500, and 1000 mg/kg
body weight) for 14 days to evaluate its hepatotoxicity and nephrotoxicity. No
toxicity on the liver and kidney organs was detected in the mice when GT was used
at less than 1000 mg/kg [54]. The Chinese medicinal plant rich in PGG, Galla
chinensis, was also studied for its acute and subchronic oral toxicity. No acute oral
toxicity was produced in rats using the oral dose of 5760 mg/kg. The no-observed--
adverse-effect level was lesser than 1500 mg/kg body weight/day in the subchronic
oral toxicity study. This dose is three times higher than the recommended dose for
clinical application. In addition, the Galla chinensis serum did not show any side
effects to rats in the central nervous system, cardiovascular system, and respiratory
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system [55]. Although these findings consider that GT and PGG are nontoxic com-
pounds, further investigations are needed to prove their biosafety.
4.3 Functional properties
Regarding its pharmacological potential, GT has been suggested to prevent several
diseases and possess different activities [56]. Gallotannin inhibited microbial growth
of both Gram-positive and Gram-negative pathogens through its antimicrobial activ-
ity [57]. Gallotannin precursor, PGG, had an antiviral activity versus Herpes simplex
virus type 1 (HSV-1) [58] and a high anti-inflammatory effect against atherosclerosis
[59]. This effect was mediated by poly(ADP-ribose) glycohydrolase (PARG) path-
way, whereby GT was found to inhibit PARG and thus trigger nuclear accumulation
of poly (ADP-ribose) (PAR). Poly ADP-ribosylation is a posttranslational modifica-
tion of proteins operated by poly (ADP-ribose) polymerases (PARPs). Studies have
shown that inhibition of PAR formation impairs the expression of several genes
involved in the inflammatory response. The antioxidant activity of PGG was associ-
ated with the inhibition of prooxidant enzymes [60]. The antidiabetic effect of PGG
was mediated by the activation of insulin receptor associated with the transportation
of glucose in the adipocytes and the reduction of blood glucose and insulin level in
diabetic animals [61]. The anticancer effect of GT will be discussed in detail in the
next section. Figure 1 summarizes the mechanisms of action of GT on cancer cells.
4.4 Mechanisms of anticancer activity of gallotannin
Gallotannin is a polyphenol that possesses interesting anticarcinogenic proper-
ties. The effect of GT in different cancer cell lines was explored by many
researchers. Different programmed death mechanisms by GT were detected in
different kinds of cancers and even in different cell lines of one type of cancer.
Table 1 represents GT anticancer effect.
4.4.1 Gallotannin and apoptosis
Gallotannin has the ability to induce apoptosis in HCT116 (p53/) and
HCT116 (p21/) colon cancer cell lines through the induction of Bax/Bcl-1
Figure 1.
Schematic diagram of the anticancer mechanisms of Gallotannin. GT induces apoptosis, senescence and
autophagy and inhibits cellular proliferation and angiogenesis.
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protein level [65]. Gold nanoparticle formulated tannic acid (AuNP-TA) was also
used against colorectal cancer, and apoptosis was detected in HCT116 cell line
through the upregulation of the expression of caspase3 and 9, Bak, and Bax; loss
of mitochondrial membrane potential; and release of cytosolic cytochrome c [66].
In liver cancer HepG2 hepatocellular carcinoma cell line, GT attenuated the expres-
sion of pro-caspase9, pro-caspase3, Bcl2, and integrin β1 and cleaved poly(ADP)-
ribose polymerase [68]. Gallotannin dramatically induced apoptosis through the
expression of p53 and active caspase-3 and fragmented DNA in A549 human lung
carcinoma cells [69]. In DU145, PC-3, and M2182 prostate cancer cell lines, the
inhibition of Mcl-1 and activation of caspases were critically involved in GT-
induced apoptosis [70]. Another study using prostate cancer cell lines showed that
Cancer type Cell lines Cell death
type
Molecular mechanism Reference
Colon HCT116 p53/
HCT116 p21/
Apoptosis Increased Bax/Bcl2 ratio [65]
HCT116 p53/
HCT116 p21/
HCT116 p53+/+
Senescence Enhanced ROS [64]
Liver HepG2 Apoptosis Pro-caspase3/9; Bcl2; PARP
cleavage
[68]
HepG2
SK-Hep1
Senescence SA-β-gal activity; p21;
IL6
[71]
[81]
SK-Hep1
HepG2
Autophagy LC3; LC3B-II; Beclin1 [81]
Lung A549 Apoptosis Caspase3; p53 [69]
A549 Senescence IL6 [81]
A549 Autophagy LC3-II
Prostate DU145
PC-3, m2182
Apoptosis Caspases; Mcl-1
UPR pathway
[70]
[72]
TRAMP-C2
PC-3
Autophagy AKT; S6K; 4EBP1 [84]
Leukemia T-cells Jurkat Apoptosis Bax [73]
Breast MDA-MB-231
MCF-7
Apoptosis Caspase3
Bak; FADD
[74]
[75]
MCF-7
SKBr3
Senescence IL6
ROS
[81]
[82]
MCF-7 Autophagy LC3-II [81]
Cervical HeLa Apoptosis Loss of MMP [76]
Necrosis Increase sub-G1 cells
Leukemia HL-60RG Apoptosis ROS [77]
Esophageal TE-2 Apoptosis Bax; Bcl2; XIAP [62]
Gingival GSCC Apoptosis Bcl2; Bax; cytochrome c [63]
Acute myeloid
leukemia
HL-60 Apoptosis Caspases; PARP cleavage;
cytochrome c
[78]
Glioma (brain) HS 683 Apoptosis Caspases3/9; PARP; ROS [79]
Table 1.
Anticancer effects of GT and its programmed cell death mechanisms and molecular targets.
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tannic acid can promote apoptosis via the ER stress-mediated UPR pathway [72].
The inhibition of the proteasome by TA in Jurkat T cells was associated with Kip1
accumulation of the cyclin-dependent kinase inhibitor p27 and pro-apoptotic pro-
tein Bax and was accompanied by the induction of G1 arrest and apoptosis [73].
Gallotannin regulates apoptosis via increased expression of active caspase-3 and
cyclooxygenase-2 (COX-2) expression through PI3-kinase and p38 kinase pathway
in MDA-MB-231 human breast cancer cells [74]. In the human breast adenocarci-
noma MCF-7 cells, GT was able to cause apoptosis by increasing the percentage
ratios of apoptotic proteins Bak and FADD [75]. Gallic acid induced apoptosis and/
or necrosis in cervical cancer HeLa cell line, which was accompanied by the loss of
mitochondrial membrane potential (MMP; DeltaPsi(m)) [76]. Intracellular ROS
induced by gallic acid, especially H2O2, plays an important role in eliciting an early
signal in apoptosis in leukemia HL-60RG cells [77]. Gallic acid induced apoptosis in
esophageal cancer cells (TE-2) via the upregulation of Bax and downregulation of
anti-apoptosis proteins such as Bcl2 and XIAP [62]. Tannic acid induced apoptosis
in gingival squamous cell carcinoma (GSCC) via the inhibition of Bcl-2 and increase
of the mitochondrial localization of Bax leading to the loss of mitochondrial mem-
brane potential, resulting in the release of cytochrome c to the cytosol [63]. The
combination of tannic acid with As2O3 induced apoptosis in acute myeloid leukemia
(AML) HL-60 cell line through the activation of the caspase cascade, cleavage of
poly (ADP-ribose) polymerase, disruption of mitochondrial membrane potential,
and release of cytochrome c [78]. Treated with GT, HS 683, a glioma cell line,
showed an activation of pro-caspase 3 and caspase 9, cleavage of poly (ADP-ribose)
polymerase, loss of mitochondrial membrane potential, and increased intracellular
ROS production [79].
4.4.2 Gallotannin and cellular senescence
In HCT116 human colon cancer cells wildtype for p53 and p21 and null for these
genes, GT caused senescence independent of p21 and p53 with the partial involve-
ment of ROS in this senescence effect [64]. Gallotannin increased the subG1 popu-
lation and induced senescence via upregulation of p21 and caused G1 arrest and
higher SA-β-gal activity in hepatocellular carcinoma (HCC) HepG2 and SK-Hep1
cell lines [71]. The GT precursor (PGG) was found to induce S-phase and G1 cell
cycle arrest in breast [80] and prostate cancer cells [67]. HepG2 human liver cancer
cells, MCF-7 human breast cancer cells, and A549 human lung cancer underwent
senescence upon treatment with PGG. These cells acquired enlarged and flattened
morphology which was associated with a significant increase in the level of both
IL6 mRNA and its secretory protein which is the key component of senescence-
associated secretory phenotype (SASP) [81]. Senescence like S response, also
known as premature senescence, is mediated by the intracellular ROS generation.
PGG induced senescence like S phase arrest in HepG2, Huh-7 human hepatoma cells
and SKBr3 human breast cancer [82].
4.4.3 Gallotannin and autophagy
In SK-Hep1 hepatocellular carcinoma cell line, GT induced autophagic features
by increasing LC3 punctate, LC3B-II conversion, autophagic vacuoles, and
decreased expression of Beclin1 [71]. HepG2 human liver cancer cells, MCF-7
human breast cancer cells, and A549 human lung cancer cells treated with PGG
increased the LC3-II level, a sign of autophagy [81]. A new molecular nanoparticle
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based on iron(III)-tannic complexes (Fe–TA NPs) induced autophagic cell death in
HepG2 cells via upregulation of LC3 mRNA expression and autophagosome forma-
tion [83]. Autophagic responses were observed in human DU145 and PC-3 prostate
cancer xenografts in nude mice detected by the formation of autophagosomes. As
for molecular changes, a rapid inhibition of the phosphorylation of mammalian
target of rapamycin-downstream targets S6K and 4EBP1 was observed by PGG in
PC-3 and TRAMP-C2 cells but not that of mammalian target of rapamycin itself,
along with increased AKT phosphorylation [84].
4.4.4 Gallotannin and necrosis
Ammar et al. showed a necrotic effect of the crude extract of Terminalia chebula
retz., fruit containing tannic acid. Tested on many cancer cell lines derived from
many cancer types such as breast, prostate, and osteosarcoma, the extract induced
necrosis when used at higher concentrations [85]. A similar effect was detected
when GT was used at higher doses in HeLa cells whereby cell death was marked by
an increase of sub-G1 cells [76].
4.4.5 Antiangiogenic effect of gallotannin
Angiogenesis is defined as a process by which new blood vessels are formed and
is a crucial process for tumor progression. The activation of VEGFR-2 is specific for
vascular endothelial cells to promote migration during angiogenesis. Gallotannin
effectively inhibited this process through downregulation of VEGF leading to the
inhibition of endothelial cell angiogenesis. The inhibition of VEGF was correlated
with the reduction of eNOS, a mediator of vasodilatation [86]. An upregulation of
SDF-1 and inhibition of CXCR4 allowed the mobilization of pro-angiogenic hema-
topoietic cells. Gallotannin dramatically decreased the SDF-1/CXCR4 interaction
which suppressed tumor angiogenesis [87].
4.4.6 Antiproliferation effects of gallotannin
Gallotannin was found to interfere with the activation of the proliferation path-
ways including NF-ĸB, PI3K/AKT/mTOR, JAK/STAT, and many others. In colon
cancer, GT inhibited NF-ĸB pathway [88]. In breast cancer, GT caused ROS-
dependent upregulation of AMPK and downregulation of the AKT/mTOR pathway
[89] and PI3K/AKT pathway [90], while it inhibited EGFR/STAT1/3 and enhanced
p38/STAT1 signaling pathway [91]. Gallotannin also inhibited JAK2/STAT3 path-
way in gingival squamous cell carcinoma [63]. Ras/MAPK is also suppressed by GT
[87]. Gallotannin was found to inhibit JAK/STAT pathway in HCT116 colon cancer
cells by our group (Gali-Muhtasib et al., unpublished findings).
5. Conclusion
With its pleiotropic molecular mechanisms of action on cells ranging from
apoptosis, senescence, autophagy, necrosis, antiproliferative, and antiangiogenic
effects, Gallotannin seems to be an interesting compound from natural sources with
minimal side effects and high effectivity against different types of cancer. Further
research including preclinical and clinical studies may propose the use of
gallotannin as an anticarcinogenic drug.
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